Trial Profile
Pilot Study: The LIPL-PLATELET Study LIPid paneLs And PLATELET activity in coronary heart disease
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Alirocumab (Primary) ; Atorvastatin; Rosuvastatin
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms The LIPL-PLATELET Study
- 07 Sep 2018 New trial record